Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)

This study has been terminated.

Sponsor:

Collaborator:

Hoffmann-La Roche

Information provided by:

French National Agency for Research on AIDS and Viral Hepatitis

ClinicalTrials.gov Identifier:

NCT00122590

First received: July 20, 2005

Last updated: July 29, 2005

Last verified: July 2005

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	March 2005
Estimated Primary Completion Date:	No date given